Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

309 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Completed

Campath-1H + FK506 and Methylprednisolone for GVHD

NCT00109993

Conditions
Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations
  • Mt. Sinai Medical Center New York, United States
  • Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Oregon Health Sciences University Portland, Oregon, United States
View Trial Details
Completed

Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer

NCT00064285

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +25 more
Locations
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University Cleveland, Ohio, United States
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Massey Cancer Center at Virginia Commonwealth University Richmond, Virginia, United States
View Trial Details

Related conditions